Free Trial Information
BioCentury | Mar 21, 2011
Financial News

Pro-Pharmaceuticals financial update

...million of its securities. Pro-Pharmaceuticals, which closed Friday at $1.09, has 67.7 million shares outstanding. Pro-Pharmaceuticals Inc....
Read More
BioCentury | Mar 14, 2011
Company News

Pro-Pharmaceuticals management update

Pro-Pharmaceuticals Inc. (OTCBB:PRWP), Newton, Mass. Business: Cancer, Drug delivery Transitioned: Peter Traber to president and CEO, while remaining a director and CMO; he replaces Theodore Zucconi, who remains a director WIR Staff cancer...
Read More
BioCentury | Jan 17, 2011
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock

Pro-Pharmaceuticals Inc. (OTCBB:PRWP), Newton, Mass. Business: Cancer, Drug delivery Date completed: 1/6/11 Type: Private placement of convertible preferred stock Raised: $2.1 million Shares: 212 Price: $10,000 Investors: Accredited investors WIR Staff cancer...
Read More
BioCentury | Jun 21, 2010
Company News

Pro-Pharmaceuticals management update

Pro-Pharmaceuticals Inc. (OTCBB:PRWP), Newton, Mass. Business: Cancer, Drug delivery Hired: Peter Traber, a director, as acting CMO; he will remain chairman and CEO of TerraSep LLC WIR Staff...
Read More
BioCentury | May 17, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...placement of convertible preferred stock and warrants Raised: $570,000 Shares: 285,000 Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
BioCentury | May 10, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...placement of convertible preferred stock and warrants Raised: $310,000 Shares: 155,000 Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
BioCentury | Mar 15, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...Private placement of convertible preferred stock and warrants Raised: $335,000 Investor: 10X Fund L.P. Note: Pro-Pharmaceuticals...
Read More
BioCentury | Feb 8, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...Private placement of convertible preferred stock and warrants Raised: $325,000 Investor: 10X Fund L.P. Note: Pro-Pharmaceuticals...
Read More
BioCentury | Dec 14, 2009
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...preferred stock and warrants Raised: $325,000 Shares outstanding prior: 51.4 million Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
BioCentury | Nov 9, 2009
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...Type: Private placement of convertible preferred stock and warrants Raised: $310,000 Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
Items per page:
1 - 10 of 76
BioCentury | Mar 21, 2011
Financial News

Pro-Pharmaceuticals financial update

...million of its securities. Pro-Pharmaceuticals, which closed Friday at $1.09, has 67.7 million shares outstanding. Pro-Pharmaceuticals Inc....
Read More
BioCentury | Mar 14, 2011
Company News

Pro-Pharmaceuticals management update

Pro-Pharmaceuticals Inc. (OTCBB:PRWP), Newton, Mass. Business: Cancer, Drug delivery Transitioned: Peter Traber to president and CEO, while remaining a director and CMO; he replaces Theodore Zucconi, who remains a director WIR Staff cancer...
Read More
BioCentury | Jan 17, 2011
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock

Pro-Pharmaceuticals Inc. (OTCBB:PRWP), Newton, Mass. Business: Cancer, Drug delivery Date completed: 1/6/11 Type: Private placement of convertible preferred stock Raised: $2.1 million Shares: 212 Price: $10,000 Investors: Accredited investors WIR Staff cancer...
Read More
BioCentury | Jun 21, 2010
Company News

Pro-Pharmaceuticals management update

Pro-Pharmaceuticals Inc. (OTCBB:PRWP), Newton, Mass. Business: Cancer, Drug delivery Hired: Peter Traber, a director, as acting CMO; he will remain chairman and CEO of TerraSep LLC WIR Staff...
Read More
BioCentury | May 17, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...placement of convertible preferred stock and warrants Raised: $570,000 Shares: 285,000 Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
BioCentury | May 10, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...placement of convertible preferred stock and warrants Raised: $310,000 Shares: 155,000 Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
BioCentury | Mar 15, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...Private placement of convertible preferred stock and warrants Raised: $335,000 Investor: 10X Fund L.P. Note: Pro-Pharmaceuticals...
Read More
BioCentury | Feb 8, 2010
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...Private placement of convertible preferred stock and warrants Raised: $325,000 Investor: 10X Fund L.P. Note: Pro-Pharmaceuticals...
Read More
BioCentury | Dec 14, 2009
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...preferred stock and warrants Raised: $325,000 Shares outstanding prior: 51.4 million Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
BioCentury | Nov 9, 2009
Financial News

Pro-Pharmaceuticals completes private placement of convertible preferred stock and warrants

...Type: Private placement of convertible preferred stock and warrants Raised: $310,000 Investor: 10X Fund Note: Pro-Pharmaceuticals...
Read More
Items per page:
1 - 10 of 76